Prostate cancer
Conditions
Interventions
None listed
Sponsors
working group of heavy ion therapy for genitourinary tumor, Gunma university
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1) Histologically proven primary prostate adenocarcinoma 2) Gleason score is diagnosed 3) T1c-T3N0M0(2009, UICC 7th) 4) PSA value before biopsy is measured 5) Age at registration is 20-80 6) Performance status is 0-2 7) Diagnosis is informed 8) Having the ability to consent
Exclusion criteria
Exclusion criteria: 1) Past radiotherapy to the pelvic region 2) Past physical treatment of the prostate (TUR-P, HIFU, etc.) 3) Past chemotherapy within 4 weeks 4) Life expectancy is less than 6 months 5) Multiple malignancies within 5 years 6) Androgen deprivation therapy period will be over than 8 months at the end of carbon ion radiotherapy 7) Castration refractory 8) Denial for the protocol androgen deprivation therapy 9) Steroid and anti-androgen therapy for other disease 10) Severe comorbidity 11) Judged inappropriate for this study by physicians
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 5-yr biochemical relapse free survival | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) 5-yr overall survival 2) 5-yr cause specific survival 3) 5-yr local control 4) acute toxicity 5) late toxicity 6) QOL | — |
Countries
Japan
Contacts
Public ContactHidemasa Kawamura
Gunma University Heavy ion medical center
Outcome results
None listed